Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Jordan flag Jordan · Delayed Price · Currency is JOD
1.160
0.00 (0.00%)
At close: Jun 7, 2026
Market Cap54.74M +36.0%
Revenue (ttm)78.84M -2.6%
Net Income6.59M +78.9%
EPS0.16 +50.2%
Shares Out 47.19M
PE Ratio7.34
Forward PEn/a
Dividend0.03 (2.59%)
Ex-Dividend DateApr 28, 2026
Volume18,909
Open1.150
Previous Close1.160
Day's Range1.140 - 1.160
52-Week Range1.090 - 1.310
Beta0.19
Analystsn/a
Price Targetn/a
Earnings DateJul 30, 2026

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatology, ophthalmology, and oncology; and cereal and milk formula products for infan... [Read more]

Industry Pharmaceutical Preparations
Founded 1975
Employees 1,111
Stock Exchange Amman Stock Exchange
Ticker Symbol DADI
Full Company Profile

Financial Performance

In 2025, ASE:DADI's revenue was 81.56 million, an increase of 2.36% compared to the previous year's 79.68 million. Earnings were 6.55 million, an increase of 82.56%.

Financial Statements